A new Tel Aviv University study reveals a novel way of detecting brain micrometastases months before they transform into malignant inoperable growths. According to the research, micro-tumor cells hijack astrogliosis, the brain's natural response to damage or injury, to support metastatic growth. This knowledge may lead to the detection of brain cancer in its first stages and permit early intervention.
A new scientific study has characterized a checkpoint protein that allows certain brain tumor cells to avoid the immune system. Tumors regularly avoid detection by decorating themselves with proteins that mimic those found on healthy cells.
The effects of ketogenic diets are not limited to seizure prevention. Ketogenic diets have shown beneficial effects and are being studied as therapeutic options for an impressively high range of neurological disorders.
Researchers at the Salk Institute have discovered a crucial key to how these tumor cells proliferate so fast and also how to use the finding into a target for cancer treatment. The details of the study finding were published recently in the journal Science Advances.
Computer-guided intra-operative brain mapping, proton beam radiation therapy and breakthroughs in immunotherapy among advances to be discussed
Pablo received devastating news at age 25: He had a terminal brain tumor and only between 6 and 9 months to live. He was given no hope of a cure. After studying online, Pablo chose to implement a ketogenic diet instead. Two years later, he’s still miraculously alive and the tumor is apparently not even growing.
Brain tumors are one of the rare forms of cancers but can be deadly if left untreated. A new discovery has led to the promising cure of brain tumors with the use of Aspirin in its liquid form.
The three-year study showed for the first time that a dendritic cell vaccine in combination with the antibody blockade of an immune cell surface receptor known as PD-1, generates a more effective immune response against glioblastoma than the use of either treatment alone.
New research at Washington University School of Medicine in St. Louis provides clues to why some patients with glioblastoma fare worse and identifies a drug target that potentially could improve survival.
Researchers at Yale University have developed a new method to quantitatively screen cell migration responses of glioma cells to platelet-derived growth factor (PDGF).
A new breakthrough in brain cancer research has shed light on how fatal brain tumors grow and has introduced a new drug target for treatment of the disease. Findings suggest that instead of growing through sugar consumption, glioma – a type of malignant brain tumor – are fueled by fats.
Researchers at the University of North Carolina are working to perfect stem-cell research after a discovery made regarding glioblastoma. The research team has found that surgically removing these brain tumors causes cancer to grow 75 percent faster than before surgery.
The basic scientific consensus surrounding glioma, the most common form of fatal brain tumor that affects every four in 100,000 people, is that sugars fuel its growth. However, a new study from Newcastle University shows that fats are its primary energy source.
New treatments are urgently needed, and in a study published in eLife, the team shows that targeting just one protein has two effects, it both halts the division of the cancer cells, and stops these cells from spreading through normal tissue, a two-in-one approach.
Using an engineered protein, researchers think they can direct chemotherapy to hard-to-reach and treatment-resistant tumors that could help reduce symptoms of the treatment while increasing its efficacy ... killing cancer while not harming surrounding healthy cells.
One of the biggest problems with brain cancer treatment is that only a limited amount of chemotherapy drugs make it through. A team of French scientists have recently tested a promising answer to that issue: an ultrasound implant that they designed to temporarily make this "blood-brain barrier" permeable.
In a surprising twist, benign brain tumors that have previously been tied to obesity and diabetes are less likely to emerge in those with high blood sugar, new research has found.
The cells lining blood vessels in the brain form tight, tough-to-penetrate junctions that prevent toxic molecules from slipping into the brain.
Unfortunately, this blood-brain barrier also blocks cancer drugs from reaching tumor cells in the brain.
When it comes to battling a particularly aggressive form of brain tumor, more extensive surgeries may be best to boost patient survival, researchers have concluded. The brain cancer -- called glioblastoma multiforme -- is often treated with surgery, radiation therapy and chemotherapy.
Brain cancer patients might benefit from an implantable ultrasound device that appears to enhance chemotherapy treatment, a small study says. Researchers tested the experimental device on 15 patients with recurrent glioblastoma, a particularly deadly brain cancer.
A new study suggests that blocking an enzyme called PRMT5 in tumor cells could be a promising new strategy for the treatment of glioblastoma (GB), the most aggressive and lethal form of brain cancer.
Advanced medications are available to treat the brain tumors. Increasing pharmaceutical R&D spending is expected to provide the lucrative growth for the global brain tumor treatment market over the forecasted period.
Johns Hopkins Medicine researchers report they have developed an experimental laboratory test that accurately clocks the “speed” of human brain tumor cell movement along a small glass “track.”
It seems like brains have finally appeared on the 3D printing radar. Just two weeks ago, Scottish researchers revealed that they were using 3D printed brain tumor replicas to push cancer research, and now researchers from Aston University are going even further.
Post Graduate Medical Institute Principal and Lahore General Hospital Prof Khalid Mahmood has said that a modern method of operation through nose has been introduced for removing brain tumor.
New data at the American Society of Clinical Oncology annual conference in Chicago took a look at how liquid biopsies could influence how we treat cancer. These tests rely on something called "circulating tumor DNA", or the bits of DNA that are released from dying tumor cells into the bloodstream.
The clinical evaluation of various anti-GD 2 monoclonal antibodies in children with neuroblastoma has been exclusively focused on treatment of patients after recovery from consolidation, in a state of ‘minimal residual disease’. This is because traditionally chemotherapy has been thought to be too immunosuppressive to combine with monoclonal antibodies.
The Heriot-Watt team will 3D print brain tumour (glioma) stem cells and other types of cells isolated from patients’ brain tumors, to recreate tumor-like constructs which should give much closer results to human tumors and reduce the current dependence on animal testing.
Researchers have developed an experimental brain cancer treatment that uses a tumor-killing virus called Toca 511 to destroy cancer cells. A new study has uncovered an experimental brain cancer treatment that might successfully extend the lives of patients two-fold using a virus.
Now, a new treatment shows promise. It uses stem cells grown from the skin and placed into a bandage-like material created at N.C. State University. That material is then put into the brain following surgery to remove a tumor. The stem cells will crawl and find the main tumor but also crawl and find all those little invasive fingers and roots that are so hard to get.
In a small clinical trial with brain cancer patients, a tumor-seeking virus successfully invaded cancer cells and smuggled in molecular detonators, allowing doctors to selectively blast the deadly growths with a toxic drug. The virus-drug combo nearly doubled their average survival time while showing no dangerous side effects.
According to new study conducted by US federal on rats, mobile phone radiation did increase rats' brain tumors in males. It raises concerns as smartphone is being used so much by so many people on a daily basis and they are always carried along with each person during the day.
The gamma knife treatment for brain tumors, available at HCA Virginia’s Johnston-Willis Hospital in Chesterfield County, is revolutionary for some patients. But that help is restricted to patients whose tumor is small — smaller than 3 centimeters. Otherwise, courses of action are widely different.
The study targeted rodents that were given doses of radiation every day for two years. Results produced were released on Friday that showed many male and female rodents developed brain and heart tumor after the experiment.
“Both the House and Senate have now spoken on the importance of expanding federal research into brain cancer,” said Elizabeth WILSon, president and CEO, American Brain Tumor Association. “We are grateful to Senator Ed Markey (D-MA) for making this request, and we also thank the Senate Appropriations Committee for listening to our community and including this in their annual defense spending bill.”
A new Neurology study investigated genes in the immune system and identified eight immune genes that may be linked to patients’ length of survival after developing the cancer.
A study using nanotechnology to treat brain tumors got such good results, the researchers initially questioned themselves. But further testing showed the results held up.
Researchers at the University of Miami, Florida International University and Nichols Children's studying ways to pierce the blood-brain barrier to treat brain tumors.
Proton beam therapy works differently from conventional radiation treatments, which rely on X-rays. Birusingh was the first patient to undergo the treatment— which uses a three-story, 200,000 pound machine— at the hospital.
Researchers have studied possible causes behind the development of brain tumors. The results show differences in expression of certain molecules known as metabolites when comparing healthy individuals with people who would eventually develop brain tumors. The greatest difference were found when looking at vitamin E.
The process would use a re-engineered polio virus, injecting it directly into the brain. The polio attacked the tumor, first causing it to swell, then awakening the immune system to attack the tumor.
National Brain Tumor Society dedicated to the brain tumor community, together with Oligo Nation, a community-driven non-profit dedicated to funding translational oligodendroglioma research, today announced $250,000 in grant-funding for a preclinical research study of an immunotherapeutic approach to oligodendroglioma treatment.
Researchers have shown previously that the therapeutic ketogenic diet (KD) prolongs survival in mouse models of glioma, explained by both direct tumor growth inhibition and suppression of pro-inflammatory microenvironment conditions. The aim of this study is to assess the effects of the KD on the glioma reactive immune response.
A team from the International School for Advanced Studies (SISSA) in Trieste has obtained very promising results by applying gene therapy to glioblastoma. Tests in vitro and in vivo on mice provided very clear-cut results, and modelling demonstrates that the treatment targets at least six different points of tumour metabolism.
A bold experiment to kill a vicious form of brain cancer has been granted breakthrough status by the Food and Drug Administration. Results in the earliest stage of testing have been so remarkable, the FDA wants to fast track the treatment to speed it to market.
The electrodes, battery pack and knit cap are the outward signs of Ledesma’s treatment. Attached to his head are 36 ceramic electrodes, which are attached to a battery pack that emits electrical impulses.
New technologies have been developed to improve the efficacy of treating a wider range of tumors, especially in delicate locations like the brain. The progressive cancer care and imaging center was among the first to deliver an emerging form of advanced radiation therapy called stereotactic radiosurgery (SRS). Now known as the Veterinary Radiosurgery and Imaging Center (VRIC), the leading-edge practice is part of a national network of cancer care centers operated by PetCure Oncology.
The blood-brain barrier is a natural defense system that prevents harmful substances in the blood from entering the brain. Doctors may have found a way to get past the barrier to treat cancer patients which may allow them to deliver chemotherapy drugs directly into the brain.
Scientists have used sophisticated pharmacologic modeling and simulation to translate preclinical findings into a successful phase I clinical trial of a chemotherapy agent for treatment of ependymoma. The research marked the first time the approach has been used to calculate drug doses for a clinical trial in pediatric brain tumor patients.
We’ve heard it a gazillion times that cell phone use can cause tumor in brain. But fret not all you mobile phone users out there, there is no link between mobile phone use and brain cancer, reveals a new, long-running study.
Removing every last cancer cell or killing them all with radiation is at best a hit-and-miss solution. Fewer than 10% of those who are afflicted with gliomas live five years. Therefore, news from scientists in Belgium working with mice and using cancer vaccines against gliomas is encouraging, if not remarkable.
The fight against deadly forms of brain cancer, such as glioblastoma, could soon benefit from a major breakthrough, thanks to A*STAR researchers. The team has found a new link between cancer cell growth and its microenvironment.
Neurosurgeons using lasers to treat brain cancer have discovered that the technique breaks down the blood-brain barrier. The blood-brain barrier is sort of a natural "security system" that shields the brain from toxins in the blood but also blocks potentially helpful drugs such as those used in chemotherapy.
Oncurious in Leuven (Belgium) was launched as an emerging oncology company focused orphan drugs for the treatment of pediatric cancers. Its current candidate is preparing for a phase I/IIa trial for the treatment of relapsed or refractory medulloblastoma – a rare, life-threatening brain tumor that mainly affects children.
Glioblastoma tumors were successfully infiltrated by investigational chimeric antigen receptor (CAR) therapy with an acceptable safety profile, according to phase 1 study results presented at the American Association for Cancer Research 2016 Annual Meeting.
A leading medical device company in the field of nanomedicine focused on oncology, today announced that Vivantes Friedrichshain, Department of Neurosurgery has initiated Commercial NanoTherm(TM) Treatments for brain cancer.
Optune is an FDA-approved portable, noninvasive device that delivers Tumor Treating Fields (TTFields) therapy to patients with newly diagnosed and recurrent glioblastoma.
A key player in brain tumor formation has been found that may lead to new therapies for a deadly and incurable cancer. The study is the first to show that a protein called OSMR (Oncostatin M Receptor) is required for glioblastoma tumours to form.
Immunotherapy represents an exciting advance in cancer treatment that harnesses the immune system to seek and destroy cancer cells.
In the study, researchers found that people who regularly took aspirin had a nearly 34 percent lower risk of a type of brain tumor called a glioma, compared with people who didn't take aspirin regularly.
Immune cells engineered to seek out and attack a type of deadly brain cancer known as glioblastoma (GBM) were found to have an acceptable safety profile and successfully migrate to and infiltrate tumors researchers reported.
Research demonstrated a significant enough link between children having acquired chickenpox and their reduced likelihood of developing brain cancer that the results shouldn’t be dismissed as coincidence.
University of Florida experts examined mice models of human glioblastoma and discovered that a high-fat, low carbohydrate diet can help to stall the development of tumor cells and increase lifespans by 50 percent.
It is more like a sensor that surgeons can run over tissue matter and supposedly in half a second, it will be able to tell the surgeon which part of the tissue is tumorous and which part isn’t, so like we said, it helps reduce the rate of errors.
Be prepared for goosebumps!
If you want to see more on this, watch this 10:39 video on this amazing relationship between player and patient.
Scientists discovered a compound in blue-green algae called coibamide A
It cuts off cancer cells' communication with blood vessels and other cells.
They studied 251 patients -- half of whom underwent radiation treatments only, half underwent both radiation and chemotherapy treatments. The researchers learned that those who received both treatments lived an average of 5 1/2 years longer, and many are doing well 10 years later.
A new test can help doctors pinpoint what is driving the tumor and better target their treatment early on. This time, doctors took a small sample of his tumor and ran it through cutting-edge molecular testing designed to pick up genetic mutations. It’s called Glio Seq.
Much cancer research is focused on immunotherapy rather than chemotherapy for treatment. Immunotherapy stimulates the body’s own immune system to fight a malignancy and has numerous advantages over chemotherapy.
Removing a brain tumor is a delicate task, if not done properly it can have catastrophic consequences, such as brain damage, motor impairment or failure in controlling a vital organ function. In order to make this work more precise, a "smart scalpel" that determines whether an area is healthy or tumorous.
The study shows that in glioblastoma (GBM), the essential amino acids methionine and tryptophan are abnormally metabolized due to the loss of key enzymes in GBM cells.
When doctors detect a tumor the next course of action is typically surgery, but when it's a brain tumor, surgery isn't always an option. So what can you do? Well doctors at Avera will soon be able to take the cutting out of brain surgery.
Diffusion Pharmaceuticals Inc. CEO David Kalergis. lays out Diffusion’s plan for pivotal development of its treatment for primary brain cancer.
Medical team experimented with MRI techniques to track “natural killer” cells after they were injected with fluorine-19, a non-radioactive, naturally occurring isotope.
Doctor believes with an as-yet-to-be-determined combination of immunotherapy and precision medicine, brain cancer researchers may finally make some headway against this long intractable problem.
A next-generation immunotherapy may offer hope for treating high-grade glioma. While dendritic cell-based immunotherapy is known to be promising, this study combined dendritic cell immunotherapy with immunogenic cell death.
When doctors diagnosed a 4-year-old doctor with brain tumors, they told her parents there was little hope. But then they all decided to take the only chance they had. 3 ago, no one knew if Allison would ever walk to the bus stop. Now, it's hard keeping up with her.
What if before initiating treatment, they could go a step further and use a mini-model of the human body to see how each patient's actual tumor responds to the drugs and learn if and where the tumor is likely to spread?
A cap fitted with arrays of electrodes and worn on the head all day and all night, Optune uses alternating electric fields to disrupt the tumor in the vital process of cell division. If the cells don't divide, the tumor doesn't grow.
Scientists at Memorial Sloan Kettering Cancer Center’s Kircher laboratory have developed a biomarker that adsorbs exclusively to the surface of cancerous cells in brain tumors. The technology can be used for therapeutic purposes (surgery) as well as diagnostics, even in the early stages of cancer.
Researchers have identified a new combination therapy for the most aggressive form of medulloblastoma, a fast growing type of pediatric brain cancer.
Scientists at the nonprofit Translational Genomics Research Institute (TGen) have identified a drug called propentofylline, or PPF, that could help patients suffering from glioblastoma multiforme (GBM), a deadly form of brain cancer.
Opdivo is a new class of medicine called an immune-oncology drug. What’s unique about the drug, and as many as 100 more in pharmaceutical pipelines that are expected to work in similar ways, is how they fight cancer cells.
Researchers believe they may have found a way to turn a patient’s skin cells into cancer killing cells, leading to a “groundbreaking discovery” for brain cancer patients.
Stem cells from a patient’s own skin may help fight the most common and most aggressive forms of brain cancer, according to University of North Carolina at Chapel Hill researchers who tested the theory in a lab.
Jimmy Carter announced that his doctors are stopping his immunotherapy treatment called pembrolizumab after they saw no signs of tumors over a period of three months.
Elekta announced that its Leksell Gamma Knife® Icon™, the most precise stereotactic radiosurgery (SRS) system currently available, was used for the first time in the US on 3/1 at Sutter Medical Center to treat a metastatic brain tumor.
Moffitt Cancer Center researchers recently reported that expression of the protein BIRC3 is associated with poor survival and recurrent disease in GBM patients; and therefore may be a good therapeutic target.
Clinical outcomes were similar with the Gamma Knife Perfexion (Elekta AB) and RapidArc (Varian Medical Systems), a linear accelerator (LINAC)-based volumetric modulated arc therapy (VMAT).
Scientists from KU Leuven in Belgium say they have shown that next-generation cell-based immunotherapy may offer new hope in the fight against brain cancer.
Children with brain cancer may soon get some help from mice with the same disease. In a new paper in Science Translational Medicine, the U-M team describes how they developed a novel brain tumor model in mice.
USC School of Pharmacy researchers who led the study on mice found that the drugs stifle the growth of brain cancer, glioma or glioblastoma, by suppressing the enzyme “monoamine oxidase A,” which affects the release of emotional brain chemicals.
Early stages of testing a vaccine that targets EGFRvIII — a genetic abnormality of the epidermal growth factor receptor (EGFR) that occurs in about one-third of glioblastoma patients and that’s associated with tumor growth and resistance to therapy.
Antidepressants can shrink and stunt cancerous brain tumors that are otherwise difficult to treat, an international team of researchers has found.
Gamma Knife and RapidArc offer different strengths, they are equally effective at eradicating cancer in the brain. The Gamma Knife was slightly more effective than RapidArc at focusing the beam of radiation and RapidArc offered much quicker treatment.
VBL Therapeutics is moving to the final stage of clinical trials for its leading product, VB-111, for the treatment of brain tumor patients. The trial will compare VBL's drug used in combination with oncological drug Avastin with the use of Avastin by itself in the treatment of recurring glioblastoma.
Virtual reality is becoming increasingly useful when it comes to the medical field. Physicians used a VR headset to map a patient's brain during surgery to remove a tumor late last month.
Two small structural elements, called decorin and lumican, could be decisive in the development of a resistance to the drugs currently used for treating glioblastoma multiforme, such as temozolamide.
A team of researchers have identified a common molecular alteration in glioblastoma. They observed that the cells of this type of tumor harbor a common intrinsic defect that prevents them from degrading their genetic material during apoptosis, the most important form of programmed cell death induced by radiotherapy and chemotherapy.
The low-carb, high-fat ketogenic diet can replace chemotherapy and radiation for even the deadliest of cancers, said Dr. Thomas Seyfried, a leading cancer researcher and professor at Boston College.
A new two-drug combination, currently in use in the clinical trials, might help people diagnosed with glioblastoma to fight the disease. The researchers are using a combination of drugs to disrupt the cellular process cancer cells use to hide from the immune system.
Despite the letdown of prior research, the future looks bright for immunotherapeutics and novel targeted therapy approaches for patients with gliomas.
The use of proton radiotherapy to treat the most common malignant brain tumor in children is as effective as standard photon (x-ray) radiation therapy while causing fewer long-term side effects such as hearing loss and cognitive disorders.
As more and more health care institutions consider the viability of providing proton therapy to their patients, new research has emerged to further cement the notion that, where young lives are concerned, there is no better option currently available.
A powerful, three-way mechanism by which a mutation drives the growth of childhood brain cancers, was discovered by scientists. The team hopes the discovery will lead to better methods for diagnosing and treating these cancers, which cannot always be cured with surgery.
While mapping vessels in tumours has proven a challenge, researchers have now developed a combined MRI and ultramicroscopy 'toolkit' to study vessel growth in glioma models in more detail than previously possible.
Proton radiation is more "precisely focused" than photon radiation, which lessens the chance healthy tissue surrounding the target area will be affected.
When comparing numbers regarding IQ loss over extended periods of time, PBRT showed a decline of 0.7 IQ points per year while the traditional photon radiation treatment was marked at 1.1 points per year.
A comprehensive analysis of the molecular characteristics of explains why some patients diagnosed with slow-growing (low-grade) tumors quickly succumb to the disease while others with more aggressive (high-grade) tumors survive for many years.
Thanks to advances in science, however, there’s now a handheld microscope that can look at the brain on a cellular level while inside the operating room, and allow surgeons to decide more confidently where to stop cutting.
A new study may explain why some patients diagnosed with slow-growing, low-grade tumors end up quickly succumbing to the disease while others with supposedly more aggressive high-grade tumors survive for many years.
A local brain cancer specialist believes more lives could be saved if doctors took a closer look at individual tumors, which is the game-changing approach that saved one teen in Agoura Hills.
The iMRI is a unique set-up that melds the sterile environment of an operating room with the imaging technology of an MRI machine. It allows neurosurgeons the ability to scan patients during surgery and see a detailed image of their progress in real time.
The idea was to find a way to model all the mutations of a particular glioblastoma simultaneously, with the goal of using data from real tumors to find targets that can be effectively attacked.
The iMRI allows neurosurgeons to fully evaluate brain imaging during surgery and to image a patient while in the operating room, which allows a surgeon to ‘see’ if all the cancer has been removed before leaving the OR.
Gleostine® 5 mg capsules has been approved by the FDA . It is approved for use as a single agent treatment or with other approved chemotherapeutic agents to treat both primary and metastatic brain tumors.
"As a truly minimally invasive surgery, I anticipate that the quality of life of the laser-treated patients to be significantly improved relative to conventional surgeries where large incisions are made and significant portions of skull are removed."
While most high school students look forward to spending their summer vacations catching up on some well-deserved rest, one Cotter senior spent two weeks of his summer working on computer coding software that would aid surgeons operating on patients with brain tumors.
Dr. Tsung says, "It allows us to scan the patient as we're operating - to define what we're taking out, how much we removed, and to protect critical areas of the brain… The patient remains sterile, the brain remains open as we run into the scanner and we roll them back out."
Scientists have identified a protein interaction that is a hallmark of an aggressive subtype of medulloblastoma and that may provide a new treatment strategy. The research appears today in the scientific journal Cancer Cell.
Stem cells found in the tumors are responsible for making glioblastoma hard to treat because they are drug-resistant and self-renewing. This study is the first to focus on how the extracellular matrix surrounding the tumor affects the development of cancer stem-like cells in a 3D microenvironment.
Cells, when dividing, utilize and enzyme called Dicer. This helps cells repair any DNA damage that occurs when errors are made as cells copy genetic material again and again. Scientists have used this knowledge as a new technique to kill rapidly dividing, cancerous cells in the brain.
For patients undergoing surgery for low-grade glioma, who must be "awake" to facilitate mapping, hypnosis allows surgeons to safely remove the tumor up to functional boundaries, according to a first-of-its-kind study.
Scientists at the Salk Institute have discovered a key to how glioblastoma multiformetumor cells proliferate so quickly --and ways to turn this engine of tumor growth into a target for cancer treatment. The late Senator Ted Kennedy succumbed to this disease in just over a year.
An international research team has shown for the first time that a specific enzyme is responsible for sensing the available supply of GTP, an energy source that fuels the uncontrolled growth of cancer cells. The research underscores the enzyme’s potential to become a therapeutic target for future cancer drugs.
A technique which replaces general anesthetics was used on 37 patients undergoing surgery to remove brain tumors. Though there's been little science to back up hypnotherapy, the authors conclude that their small study's success suggests hypnosis could be a viable tool to help sedate patients during delicate brain surgery.
Progression-free and overall survival were prolonged with maintenance therapy involving tumor-treating fields (TTFields) and chemotherapy in patients with a brain tumor who had completed standard chemoradiation, according to early research findings published in JAMA.
A noninvasive, low-cost blood test was developed to help doctors diagnose some types of malignant childhood tumor Cancer. The test could enable clinicians to monitor treatment effectiveness without exposing patients to repeated doses of radiation.
The surgeons behind the study believe that this research proves that “hypnosedation” can be a valuable tool for patients with advanced brain cancers.
Patients receive injections – directly at the tumor site – of immune cells genetically modified to recognize certain markers on cancer cells.
A study of gliomas found that DNA structure was disrupted, allowing separate segments to merge and activate a growth gene. An existing chemotherapy drug may fix that.
Scientists say they have developed a novel 3D cell culture technique that allows brain tumor growth to be studied directly and without the need for complex experiments using live animals.
An electromagnetic field therapy known as tumor-treating fields could extend the lives of patients with a brain tumor when combined with routine chemotherapy, according to early research.
An MRI contrast agent that can pass through the blood-brain barrier will allow doctors to detect deadly brain tumors called gliomas earlier. This ability opens the door to make this fatal cancer treatable.
Cell biologists are taking clues from marching ants, flocking birds and other animals to learn how groups of cells move through the body. Such studies are yielding insights about cell movement during development as well as the spread of cancer.
Experimental drugs that alter cell metabolism also halted tumor growth and extended survival in mice with cancers linked to changes in the same gene, according to a new study.
Former President Jimmy Carter announced that recent brain scans found no evidence of cancer. After being diagnosed with melanoma, a very serious type of cancer affecting his liver and brain, he credited Keytruda, a new cancer drug, for shrinking his brain tumors entirely.
Researchers at the University of Basel took a close look at a signaling pathway present in most organisms and found that it suppresses the formation of specific types of brain tumor.
In a development that promises to aid vascular & brain tumor surgeons, University of Arizona bioengineers have developed a novel microscope that combines 2 images of tissue in a single view – the optical image overlaid with a fluorescence image from dye attached to tiny structures in cells.
3D printed medical models help both doctors and patients prepare for complex surgeries by providing exact replicas of patients’ body parts. With a consideration for the patients’ comfort-levels central, the Netherlands’ Radboud University Medical Center has been working on an alternative to the usual MRI or CT scans used to diagnose and treat brain tumors.
A new clinical trial in which cancer patients are given a chemotherapy drug delivered directly into their tumors is giving hope to people with a highly aggressive type of brain cancer.
The vaccine, Rintega, which was designed to enable the immune system to recognize and fight against glioblastoma multiforme, was shown to improve the survival rate of patients who were given the vaccine along with Avastin by up to two years compared to patients who were just given Avastin.
A research team at Okayama University and Kinki University developed a boron-based compound (BSH) that accumulates in malignant cells rather than in healthy cells, which can be used in radiation therapy.
Berkeley Lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier - the network of blood vessels that allows essential nutrients to enter the brain but blocks the passage of other substances.
Dr. Vogelbaum from the Cleveland Clinic and his team are studying a new tool that helps get chemotherapy past the brain's protective barrier, directly into brain tumors. The device is called a multi-port catheter and doctors are able to deliver medication through tiny tubes directly into the brain tumor.
Cancer drug developer GenSpera has reported encouraging results from phase II studies of its lead candidate mipsagargin on treating brain cancer - results showed the tolerability and indications of effectiveness of mipsagargin in advanced brain cancer patients.
Surgeons in the Neuroscience Institute at Allegheny General Hospital are now using laser energy and MRI visualization to remove brain tumors that previously were difficult to access via other minimally-invasive surgical techniques.
"The radiation therapy fields now are much more precise, similar to a sniper. It becomes very important that we don’t cause any collateral damage because the bullet we’re using is a lot more powerful, but if it’s misdirected, it can cause a lot more damage.”
For the first time, doctors have breached the human brain's protective layer to deliver cancer-fighting drugs. The Canadian team used tiny gas-filled bubbles, injected into the bloodstream of a patient, to punch temporary holes in the blood-brain barrier.
A new treatment option at Baptist MD Anderson Cancer Center could help extend the life of newly diagnosed brain tumor patients. Patients diagnosed with glioblastoma multiforme now have an additional tool that works along with chemotherapy and radiation.
Canada’s medical researchers have found a breakthrough method to deliver chemotherapy drugs using a new ultrasound technique to breach the brain’s protective membrane and sneak past the stubborn blood-brain barrier.
The preliminary success of this research opens the door for treatment of other brain diseases that are normally hindered by the protection of the blood-brain barrier, including brain tumors, Alzheimer's disease, and many psychiatric conditions.
In a significant breakthrough, the Translational Genomics Research Institute (TGen) has identified a drug, propentofylline or PPF, that could help treat patients with deadly brain cancer.
Scientists have pioneered research evidencing the use of cerebrospinal fluid (CSF) as liquid biopsy for the potential prognosis, treatment, identification and tracking of brain tumor genomic alterations not only in real time but over time.
A team of Canadian scientists has done something completely extraordinary and has permeated the blood-brain barrier (BBB) inside of a living patient to administer chemotherapy medication.
Laser Ablation - the process enables surgeons to destroy brain tumors and lesions with pinpoint precision and allows patients to avoid conventional invasive surgery.
Scientists at Toronto’s Sunnybrook Hospital have taken the next bold step in chemotherapy by developing a non-invasive procedure to treat brain tumours.
Gamma Knife Perfexion, a technology that has been referred to as the “gold standard” treatment for non-invasive radiosurgery of the brain.
The first trial failed to reduce her tumor, but in January 2014, Rooney was enrolled in a second trial that shrunk her tumor from the size of a half dollar to dime size.
The time taken to diagnose brain tumours in children in this country has been slashed thanks to new guidelines from the University of Nottingham. The guidelines and a national awareness campaign have taken the UK from one of the worst ranking countries in the world to one of the best.
thromboDx, a molecular diagnostic company announced that a 283 subject study shows that its' blood platelet based diagnostic platform enables accurate detection, classification and subtyping of cancer in the equivalent of one drop of blood.
Federal health officials on Tuesday approved a first-of-a-kind drug that uses the herpes virus to infiltrate and destroy deadly skin cancer tumors.
Research is underway at Washington University to test a new approach to cancer treatment. Beyond traditional therapies like surgery, chemotherapy and radiation, scientists want to know if the human body's own immune system can attack tumors.
A new microscope, developed in the University's Medical School, could help surgeons with the difficult task of tumor removal by showing the difference between healthy and tumorous tissue in real-time.
Research into life-extending treatments for brain cancer patients has been taking a rare turn toward the hopeful, as trials of immunotherapy and tumor treating fields (TTF) are showing promise of beneficial results. - See more at: http://www.clinicaloncology.com/ViewArticle.aspx?d=Solid+Tumors&d_id=148&i=October+2015&i_id=1236&a_id=34003#sthash.MtNvMWjy.dpuf
Danish scientists at the University of Copenhagen and the University of British Columbia may have accidentally stumbled on to a discovery that could possibly be a game changer in the fight against cancer.
When Avi Yaron found out he had an inoperable brain tumor, he didn't take it lying down. Rather than accept that his life was over, he invented the technology that saved his life and is now saving the lives of thousands of others around the world.
But a new laser-based microscopic technology may help surgeons see the difference between tumor tissue and normal brain in real-time.
An imaging technology called MR spectroscopy is allowing doctors to diagnose brain tumors without putting patients through the rigors of a brain biopsy.
With more than 100 types of cancer, glioblastoma is one of the more aggressive forms of brain cancer, which can shorten life spans anywhere from two weeks to two years. To add months to a patient's life, doctors are trying a new treatment called Optune.
The U.S. Food and Drug Administration today approved an expanded indication for the Optune device to treat patients with newly-diagnosed glioblastoma multiforme (GBM), an aggressive form of brain cancer.
The Optune device uses NovoCure’s “tumor treating fields,” which use low-intensity, intermediate-frequency alternating electric fields that limit cancer cell replication and kill cancer cells.
A rabbit virus currently being developed for cancer therapy can be paired with one of several existing drugs to deliver a more potent punch to a deadly type of brain tumor cell, researchers have found.
The Optune device delivers low-intensity alternating electric fields to the brain. The procedure is disrupting cell division and killing cancer cells.
Scientists found that combining anticoagulant drugs and antidepressants can cause cancer cells to eat themselves and hinder the progression of the killer disease.
EPFL scientists have found that combining antidepressants with anticoagulants slows down brain tumors (gliomas) in mice.
OncoRx Pharmaceuticals, Inc. is announcing its launch as an early-stage pharmaceutical company focused on the development of drug therapies that control the progression of therapy-resistant malignant tumors.
Scientists and neurosurgeons are working together to build a huge bank of pediatric brain tumor samples to advance research and find cures.
A new article published in Neurology suggests that being overweight or obese may be linked to an increased risk of developing meningioma, a type of brain tumor.
Current drugs may stop working against the most common type of brain tumor in children, medulloblastoma, but the tumor could be targeted in a new way, according to Stanford University scientists.
In research to be published in the journal eLife, a team tested a drug in mice with a brain tumor that is resistant to Vismodegib, the drug in current use. The drug, normally used to treat inflammatory lung diseases, dramatically inhibited tumor growth from the first day of treatment.
An associate professor of epidemiology at the Ohio State University led a research that found changes in the immune function five years before patients were being diagnosed with glioblastoma.
A young Chicago Bears fan who named his brain tumor after Aaron Rodgers will get to attend the season opener against the Green Bay Packers on Sept. 13
NASA scientists are working with researchers at the Skull Base Institute in Los Angeles to develop a “super instrument,” an endoscope with a 3D camera that will allow neurosurgeons to better navigate brain tissue during tumor resections.
The first group of patients has completed their initial dose of a special nanotechnology delivery of radioactive fat particles that target cancer cells in the brain, leaving the healthy tissue mostly untouched.
A new treatment for glioblastoma could enter clinical trials following the results of a new mouse study that looked at the effects of chemotherapy agent decitabine combined with T cell immunotherapy.
Investigators have discovered that determining the tumor's subgroup can be achieved noninvasively, using magnetic resonance spectroscopy (MRS).
UCLA scientists have developed a potentially promising new combination therapy for glioblastoma, the most common and deadliest form of brain cancer.
A new laser-based tool would allow surgeons to tell cancer tissue from normal brain tissue at the microscopic level while they are operating and would avoid the problem of leaving behind cells that could spawn a new tumor.
A brain tumor is not always the death sentence many people think it is. "We have good techniques and it's not as dire as people think. From a neurosurgery standpoint, we have gotten pretty good at managing these patients with our arsenal of therapies and advances."
During an operation to remove a brain tumor for the first time in Europe, the researchers used the non-invasive technique, which measures light reflected off tissue to determine whether it is cancerous or healthy.
A young man has successfully undergone pioneering brain surgery. The procedure used two technologies - a laser probe and a smart knife - that appear set to revolutionize the performance of delicate surgery.
A study highlighting high-grade gliomas in children which found better survival rates with gross total resection (GTR), specifically in girls.
Doctors are treating former president Jimmy Carter's metastatic melanoma with a Keytruda, a combination of the latest immunotherapy drug and advanced radiation. It was just approved by the Food and Drug Administration last year and is the first of its kind.
A brain tumor patient was chosen to participate in an experimental treatment. She has to wear a head wrap for 24-hours a day. "It's supposed to send radio waves or something electrical to your brain that I can't feel, but it's supposed to keeping the tumors from growing," the patient said.
epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
Scientists at The University of Texas MD Anderson Cancer Center have shown that EGFR (epidermal growth factor receptors) may be shut down with the help of a cytokine known as MIF (macrophage migration inhibitory factor). It’s a finding they believe could signal a new way to look at treating tumors.
The doctors at the University Medical Center Utrecht asked Ambroz Bajec-Lapajne to sing in order to monitor his ability to vocalize and recognize the key change during the brain tumor surgery.
Drugs called ion channel blockers might prove useful in cancer therapy, according to research findings in fruit flies and mice by UC San Francisco scientists that led to unconventional treatment of a case of metastatic brain cancer.
Drugs called ion channel blockers, which are commonly used to treat cardiac, neurological, and psychiatric disorders, might prove useful in cancer therapy.
The experiments revealed that glioblastomas, described by medical experts as highly invasive brain tumors, take longer to spread when communication between the cells that comprise them is shut down.